Cite
HARVARD Citation
Takeuchi, T. et al. (n.d.). SAT0186 Effects of denosumab, a subcutaneous rankl inhibitor, on the progression of structural damage in japanese patients with rheumatoid arthritis treated with csdmards: results from the 12-month double blind phase 3, desirable study. Annals of the rheumatic diseases. pp. 841-842. [Online].